Tag

Jyothy Labs Limited

5 articles
The non-renewal of Jyothy Labs’ Pril and Fa brand licenses by Henkel, impacting roughly 7-8% of revenue, introduces a transitional period for the company, with anticipated near-term margin softness in fiscal 2027. Jyothy Labs has initiated arbitration to safeguard its contractual rights regarding exit valuation and transition mechanisms, while simultaneously focusing on scaling its Exo dishwash liquid and developing new products to offset the revenue decline. Despite this challenge, the company’s strong financial health—marked by ₹997 crore in cash reserves and a debt-free balance sheet—positions it to navigate this shift and continue delivering shareholder returns, though investors should monitor the outcome of the arbitration and the success of the Exo brand expansion.